Magnetic resonance elastography and proton density fat fraction predict adverse outcomes in hepatocellular carcinoma.

Rex Wan-Hin HuiAlbert Chi-Yan ChanGladys LoRegina LoCura ChanClarence Nicholas KotewallLung-Yi MakWong-Hoi SheKin-Pan AuVictor AiJames FungMan-Fung YuenWai Kay Seto

Published in: Hepatology international (2022)

Pre-treatment MR elastography and PDFF over tumor and non-tumor regions demonstrated prognosticating roles in HCC. Simultaneous measurements of both metrics during conventional MR liver should be considered in the diagnostic workup of HCC.

Keyphrases

magnetic resonance
contrast enhanced
liver fibrosis
adipose tissue
magnetic resonance imaging
computed tomography
fatty acid
combination therapy
replacement therapy